Cargando…
A Chymase Inhibitory RNA Aptamer Improves Cardiac Function and Survival after Myocardial Infarction
We have reported that mast cell chymase, an angiotensin II-generating enzyme, is important in cardiovascular tissues. Recently, we developed a new chymase-specific inhibitory RNA aptamer, HA28, and we evaluated the effects of HA28 on cardiac function and the mortality rate after myocardial infarctio...
Autores principales: | Jin, Denan, Takai, Shinji, Nonaka, Yosuke, Yamazaki, Satoko, Fujiwara, Masatoshi, Nakamura, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298900/ https://www.ncbi.nlm.nih.gov/pubmed/30572223 http://dx.doi.org/10.1016/j.omtn.2018.11.001 |
Ejemplares similares
-
Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9
por: Takai, Shinji, et al.
Publicado: (2022) -
Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis
por: Takai, Shinji, et al.
Publicado: (2018) -
Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis
por: Takai, Shinji, et al.
Publicado: (2020) -
Mechanism of Albuminuria Reduction by Chymase Inhibition in Diabetic Mice
por: Terai, Kentaro, et al.
Publicado: (2020) -
Chymase as a Novel Therapeutic Target in Acute Pancreatitis
por: Kuramoto, Toru, et al.
Publicado: (2021)